About IQVIA
IQVIA is a company based in Durham (United States) founded in 1982 by Dennis Gillings was acquired by TPG in November 2009. IQVIA has raised $1.74 million across 10 funding rounds from investors including TPG, HHS and CPP Investments. The company has 88,000 employees as of December 31, 2024. IQVIA has completed 15 acquisitions, including Advanced Health Media, AllCare Plus and DMDConnects. IQVIA operates in a competitive market with competitors including Medidata, Verily, TriNetX, Signant Health and WIRB-Copernicus Group, among others.
- Headquarter Durham, United States
- Employees 88000 as on 31 Dec, 2024
- Founders Dennis Gillings
- Stage Public
-
Sectors
HealthcareTechnology
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Iqvia Holdings, Inc.
-
Annual Revenue
$16.31 B (USD)5.87as on Dec 31, 2025
-
Net Profit
$1.36 B (USD)-0.95as on Dec 31, 2025
-
EBITDA
$3.43 B (USD)1.42as on Dec 31, 2025
-
Total Equity Funding
$1.74 M (USD)
in 10 rounds
-
Latest Funding Round
Not available
-
Investors
TPG
& 3 more
-
Employee Count
88000
as on Dec 31, 2024
-
Investments & Acquisitions
Advanced Health Media
& 14 more
-
Acquired by
TPG
(Nov 05, 2009)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of IQVIA
IQVIA is a publicly listed company on the NYSE with ticker symbol IQV in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
People of IQVIA
Unlock access to complete
Unlock access to complete
Software Development Team
347 people
Leadership Team
254 people
Sales and Marketing
130 people
Operations Team
78 people
Senior Team
75 people
Human Resources and Administration
53 people
Data Analysis and Operations Team
41 people
Product Management Team
35 people
Unlock access to complete
Funding Insights of IQVIA
IQVIA has successfully raised a total of $1.74M across 10 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in IQVIA
IQVIA has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include TPG, HHS and CPP Investments.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Fund of funds focused on pre-seed and seed-stage companies
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked | |
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked |
Investor details for IQVIA
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by IQVIA
IQVIA has strategically engaged in corporate development activities, having acquired 15 companies. Notable acquisitions include Advanced Health Media, AllCare Plus and DMDConnects.
Investment portfolio details for IQVIA
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Healthcare marketing solutions are provided for personalized engagement.
|
Locked | Locked | 2019 | Locked | |
|
AI-based data analytics tools for integration and visualization are provided.
|
Locked | Locked | 2017 | Locked | |
|
Laboratory services including central labs and biomarkers are provided.
|
Locked | Locked | 2015 | Locked |
Complete acquisition details for IQVIA
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - IQVIA
Detailed financials for IQVIA
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Iqvia Comparisons
Peer comparison for IQVIA
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of IQVIA
IQVIA operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Medidata, Verily, TriNetX, Signant Health and WIRB-Copernicus Group, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
|
|
| Locked | Locked | Locked |
AI-based solutions for health management are provided.
|
|
| Locked | Locked | Locked |
Clinical trial management software is provided for researchers and professionals.
|
|
| Locked | Locked | Locked |
Signant Health is engaged in providing clinical trial technology solutions.
|
|
| Locked | Locked | Locked |
Regulatory and ethical review services for clinical research are provided.
|
Detailed competitors of IQVIA
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Iqvia
Complete news archive for IQVIA
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about IQVIA
IQVIA was founded in 1982 and raised its 1st funding round 24 years after it was founded.
IQVIA is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
Ari Bousbib is the current CEO of IQVIA.
IQVIA is a funded company, having raised a total of $1.74M across 10 funding rounds to date.
As of Dec 31, 2024, the latest employee count at IQVIA is 88,000.
Annual revenue of IQVIA is $16.31B as on Dec 31, 2025.
IQVIA was founded in 1982 and is headquartered in Durham, United States. Services are offered in clinical research, real-world evidence generation, commercialization, safety, and regulatory compliance within the healthcare and life sciences sectors. Operations span research and development, with technologies and products supporting clinical, commercial, compliance, and real-world applications. Clients include pharmaceutical manufacturers, biopharma, medtech, payers, providers, and government entities across global markets.
Yes, IQVIA is publicly traded on NYSE under the ticker symbol IQV.
IQVIA has made 15 acquisitions, including Advanced Health Media, AllCare Plus, and DMDConnects.
IQVIA has 4 investors. Key investors include TPG, HHS, CPP Investments, and European Union.
The ticker symbol of IQVIA is IQV on NYSE.